Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

The pink, white and red blob of tissue quivers in a vat of clear goop about the size of a kitchen sink. Graduate students ...

How mission plus performance can lead to sustainable success.

In the latest trading session, Medtronic (MDT) closed at $90.01, marking a -0.89% move from the previous day. This change was narrower than the S&P 500's daily loss of 0.95%. Meanwhile, the Dow ...

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...

Medtronic announced that new findings from the company-sponsored DiVERT Stroke clinical study showed women spent less time in t ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A ...

In the closing of the recent trading day, Medtronic (MDT) stood at $91.69, denoting a +0.79% change from the preceding trading day.

The company will keep the systems on the market but is asking providers to check devices for visible cracks and return ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

In December, YNHH integrated the newly FDA-approved Medtronic VitalFlow ECMO System and first used it to transfer a patient ...

Medical device industry veteran brings over three decades of expertise in M&A, as well as structured research and development (“R&D”) ...